IPO Date | August 8, 2025 to August 12, 2025 |
Listing Date | August 18, 2025 |
Face Value | ₹ 10 / Share |
Price Band | ₹ 43 to ₹ -- / Share |
Lot Size | 3000 Shares |
Total Issue Size | 37,44,000 shares (Aggregating up to ₹16.10 Cr) |
Fresh Issue | |
Offer for Sale | |
Employee Discount | |
Issue Type | Fixed Price IPO |
Listing At | NSE SME |
Share holding pre issue | 1,04,65,546 shares |
Share holding post issue | 1,42,09,546 shares |
Market Maker portion |
Medistep Healthcare LImited IPO opens on August 8, 2025, and closes on August 12, 2025.
IPO Open Date | August 8, 2025 |
IPO Close Date | August 12, 2025 |
Basis of Allotment | August 13, 2025 |
Initiation of Refunds | August 14, 2025 |
Credit of Shares to Demat | August 14, 2025 |
Listing Date | August 18, 2025 |
Cut-off time for UPI mandate confirmation | August 12, 2025 |
Investors can bid for a minimum of 6,000 shares and in multiples of 3,000 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 2 | 6,000 | |
Retail (Max) | 2 | 6,000 | |
S-HNI (Min) | |||
S-HNI (Max) | |||
B-HNI (Min) | |||
HNI (Min) | 3 | 9,000 |
Share Holding Pre Issue | 93.62% |
Share Holding Post Issue | 68.96% |
Medistep Healthcare IPO offers a total of 37,44,000 shares. Out of which 17,76,000 (47.44%) allocated to NII, 17,79,000 (47.52%) allocated to RII
Investor Category | Shares Offered | Maximum Allottees |
---|---|---|
Anchor Investor Shares Offered | |
|
Market Maker Shares Offered | 1,89,000 (5.05%) |
|
Other Shares Offered | |
|
QIB Shares Offered | |
|
NII (HNI) Shares Offered | 17,76,000 (47.44%) |
|
bNII > ₹10L | |
|
sNII < ₹10L | |
|
Retail Shares Offered | 17,79,000 (47.52%) |
|
Employee Shares Offered | |
|
Total Shares Offered | 37,44,000 (100.00%) |
Bid Date | |
Shares Offered | |
Anchor Portion Size (In Cr.) | |
Anchor lock-in period end date for 50% shares (30 Days) | |
Anchor lock-in period end date for remaining shares (90 Days) |
Incorporated on June 2023, Medistep Healthcare Limited is a pharmaceutical firm manufacturing sanitary pads, energy powder, and other pharmaceutical, nutraceutical, intimate, and surgical products. They hold themselves accountable for quality and aspire to increase their product line as a public, non-government company.
The product comprises the following:
Sanitary Pads: Medistep makes sanitary pads of superior quality, responding to the necessary feminine hygiene requirements.
Energy Powder: The firm makes energy supplements that are meant to rejuvenate and energize consumers.
Pharmaceutical Products: Medistep is involved in the business of trading of a number of pharmaceutical products to make necessary drugs readily available.
Nutraceutical Products: They deal in products which combine nutrition and pharmaceuticals, bringing about proper health and well-being.
Intimate Care and Hygiene Products: The company offers intimate care and personal hygiene products.
Surgical Products: Medistep deals in surgical products and assists medical practitioners with required equipment and instruments.
As of December 30, 2024, Medistep has revenues annually of ₹45.00 crore and Profit After Tax (PAT) of ₹4.08 crore.
As of December 28, 2024, the company has nine payroll employees. The needs of labour are based on day-paid workers, and none are under contract.
Competitive Strength:
Experienced Promoters and Management Team.
Optimize resources for quality supply and cost savings through economies of scale.
Its business includes trading in medical and healthcare products, production of DRYSTEP sanitary napkins, and VITASTEP Z energy powders.
The market capitalization of Medistep Healthcare IPO is ₹61.10 Cr.
KPI | Values |
---|---|
ROE | 29.06% |
ROCE | 38.91% |
Debt/Equity | |
RoNW | 29.06% |
P/BV | 2.67 |
PAT Margin (%) | 8.35% |
Pre IPO | Post IPO | |
---|---|---|
EPS (Rs) | 3.96 | 2.92 |
P/E (x) | 10.86 | 14.74 |
Medistep Healthcare Ltd. 05, S. No-245/B, Plot-19, T.P.S. 56, Free Way Trade Center, Nr.A-One Hotel N.H.-8 Narol Gam, Narol Daskroi, Ahmedabad, Gujarat, 382405 Phone: +91 87808 46963 Email: [email protected] Website: https://www.medistephc.com/ |
Cameo Corporate Services Limited Phone: +91-44-28460390 Email: [email protected] Website: https://ipo.cameoindia.com/ |
Lamfindia specializes in offering innovative financial solutions, including stock broker services, mutual fund investments, and IPO guidance.